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the presence and size of JBA predicts future ipsilateral
ischemic stroke.
Methods: JBAwas defined as an area of pixels with gray
scale value 25 adjacent to the lumen without a visible
echogenic cap, after image normalization. The size of a JBA
was measured in the carotid plaque images of 1121 patients
with asymptomatic carotid stenosis 50-99% in relation to
the bulb (ACSRS study), followed-up for up to 8 years.
Results: JBA had a linear association with future stroke
rate. The area under the ROC curve was 0.816. Using
Kaplan Meier curves, the mean annual stroke rate was 0.4%
in 706 patients with JBA 4 mm2; it was 1.4% in 171
patients with JBA 4-8 mm2, 3.2% in 46 patients with JBA
8-10 mm2 and 5% in 198 patients with JBA 10 mm2 (P
.001). In a Cox model with ipsilateral ischemic events
(AF, TIA or stroke) as the dependent variable, JBA (4,
4-8,8) was still significant after adjusting for other plaque
features known to be associated with increased risk (steno-
sis, GSM, presence of discrete white areas without acoustic
shadowing (DWA) indicating neovascularization, plaque
area and history of contralateral TIA or stroke. Plaque area
and gray scale median (GSM) were not significant. Using
the significant variables (stenosis, DWA, JBA and history of
contralateral TIA or stroke), this model predicted the an-
nual risk of stroke (range 0.5-10.0%). The average annual
stroke risk was 1% in 734 patients, 1-1.9% in 94, 2-3.9%
in 134, 4-5.9% in 125 and 6-10% in 34.
Conclusions: The size of JBA is linearly related to the
risk of stroke and can be used in risk stratification models.
These findings need to be confirmed in future prospective
studies or in the medical arm of randomized controlled
studies in the presence of optimal medical therapy.
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Objectives: Recently an association has been made
between Multiple Sclerosis (MS) and Chronic Cerebrospi-
nal Venous Insufficiency (CCSVI) characterized by stenosis
and reflux of the principal extracranial venous drainage
including the Internal Jugular veins (IJV) and the Azygous
veins (AZV). This is the first angiographic study to quanti-
tatively analyze the impact of percutaneous balloon angio-
plasty (PTA) on flow dynamics across these lesions.
Methods: 50 IJV formMS patients with CCSVI and 12
IJV from healthy volunteers underwent detailed angiographic
evaluation. Technical components of all venogramswere stan-
dardized. Quantitative analysis included the contrast time of
flight (TOF) from the mid IJV to the superior vena cava, and
the primary venous emptying time (PVET), quantified as
50% of venous emptying, from the IJV. The TOF and
PVET were recorded in patients with CCSVI prior and sub-
sequent to balloon angioplasty, as well in normal healthy
subjects. All data was prospectively collected, and statistical
analysis was performed using two-tailed Student’s test.
Results: Of the 50 CCSVI-MS patients with IJV ste-
nosis 70% and reflux underwent balloon angioplasty,
technical success defined as20% residual IJV stenosis was
achieved in 78% (44/50). The Table describes the pre and
post angioplasty TOF and PVET in patients with CCSVI,
as well as in healthy non-MS patients without any treat-
ment. CCSVI patients were noted to have a significant
improvement in both the TOF and PVET following bal-
loon angioplasty that paralleled healthy non-MS subjects.
Conclusions: Results of this prospective pilot study
suggest an association between MS and CCSVI, which
results in abnormally elevated TOF and PEVT through the
IJV. Furthermore, balloon angioplasty these lesions im-
proves the hemodynamic parameters that are comparable
to healthy non-MS patients.
Table.
MS patients with CCSVI
Healthy
Non-MS
Pre-
angioplasty
Post-
angioplasty
No
treatment
TOF PVET TOF PEVT TOF PEVT P value
Mean time (sec.) 5.28 12.45 2.45 6.44 2.33 6.10 .001
St. dev. 2.52 10.0 0.79 2.05 0.42 0.58
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Objectives: Relevance of training has been recognized
as a key factor for safety of Carotid stenting (CAS).
The objective of this study was to evaluate whether the
center learning curve could shortcut the training of new
trainees with CAS.
Methods: Consecutive CAS procedures performed
from 2001 to 2010 were reviewed. The learning curve
phase (years 2001-2003) was performed by the “leader
team” (“historical team”) including vascular surgeons
and interventional radiologists who first approached
CAS. Learning curve included acquisition of handle skill
with CAS procedural steps and best selection of patients
and materials. Periprocedural complications after the
learning curve in the “leader team phase” (the historical
team continued to perform all procedures in 2004-2006)
and in the “expanded team phase” (5 new trainees joined
the historical team in 2006-2010) were measured.
Results: A total of 1540 CAS were reviewed. The first
195 represented the learning curve. Of the remaining 1345
CAS, 431 were performed in the “leader phase” and 914 in
the “expanded team phase”. Individual operator volume
for the new trainees ranged from 20 to 188 CAS. Peripro-
cedural complications were similarly low in the two phases:
strokes (2.8% vs 2.2%; P  .56) major strokes (0.9% vs
0.8%, P  .75), death (0.2% vs 0%; P  .3) for the leader
and expanded team phase respectively. Mean procedure
time was longer (43 min vs 38 min) in the expanded team
phase, while rates of immediate conversions (1.0% vs
3.5%, P  .03) and mean contrast use (69mL vs 92mL;
P .0001) decreased.
Conclusions: The primary factor driving stroke reduc-
tion with CAS is the center experience. CAS complication
rate is not based on individual rules but most likely on the
center/team practice also defining how to select patients
and materials best suited for the procedure. Appropriate
learning curve of the center can reliably shortcut the train-
ing of new trainees preserving CAS safety and efficacy.
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Objectives: The purpose of this study was to evaluate
the impact of gender on late functional outcomes of lower
extremity bypass (LEB).
Methods: We reviewed 3,301 patients (1,060; 32%
females) undergoing LEB in the Vascular Surgery Group of
New England from January 2003 to June 2010 to assess
procedural outcomes, independent living, and ambulatory
status according to preoperative baseline. Logistic regres-
sion models adjusted for differences between genders and
potential confounders (age, race, smoking, indication, pre-
operative ambulation, statin use, conduit, and length of
follow up). Ambulation and living status were analyzed by
life table analysis.
Results: On univariate analysis woman had less CAD
(35% vs. 40 %, P.001), smoking (75% vs. 89%, P .002),
and autogenous conduits (63% vs. 71%, P.001). Women
had higher rates of reoperation for thrombosis (4% vs. 2%;
OR 2.09, P .001) or infection (2% vs. 1%; OR 2.36, P 
.02) without differences in graft patency (94% vs. 95%; P
.25) or mortality (2.1% vs. 2.1%; P  .84) at discharge.
Multivariate analysis showed fewer women were discharged
home (63% vs. 73%; OR 0.72, P.001) and ambulating at
discharge (90% vs. 93%; OR 0.65, P  .009) regardless of
preoperative ambulation. At long-term follow-up fewer
women lived independently (HR 1.46, P  .06) and sig-
nificantly fewer were ambulatory (HR 1.65, P  .004)
(Fig).
Conclusions: Women have similar procedural-related
complications but slightly inferior early and late functional
outcomes after LEB. These findings may help define phy-
sician and patient expectations in women before revascular-
ization.
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